BDTX-189 - Moligand™, ≥98% , Epidermal growth factor receptor erbB1 negative allosteric modulator, CAS No.2414572-47-5, Epidermal growth factor receptor erbB1 negative allosteric modulator

CAS: 2414572-47-5 Cat. No.: B414485 Fórmula: C29H29ClN6O4 Peso molecular: 561.03
Disponible para pedir
CALIDAD & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
2-Propenamide, N-[4-[[3-chloro-4-(2-pyridinylmethoxy)phenyl]amino]-7-[2-(4-morpholinyl)ethoxy]-6-quinazolinyl]-|Tuxobertinib [USAN]|N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-(2-morpholinoethoxy)quinazolin-6-yl)acrylamide|Tuxobertinib [USAN:INN]|tuxobertinib|N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-morpholin-4-ylethoxy)quinazolin-6-yl]prop-2-enamide|Tuxobertinib [INN]|BDTX189|BDTX-189|Tuxobertinib [WHO-DD]
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Talla
USA
Alemania (EU)*
Precio
Cantidad
5mg
B414485-5mg
3 Disponible
—
68,90US$
25mg
B414485-25mg
8 Disponible
—
246,90US$
100mg
B414485-100mg
3 Disponible
—
741,90US$
500mg
B414485-500mg
2 Disponible
—

2.648,90US$

3.339,90US$
Guardar 691,00 US$ (20.69%)
Enter a quantity for the sizes you want to add.

Descripción general

Information

BDTX-189 is a potent and selective inhibitor of allostericEGFRandHER2oncogenic mutations with Kd of 0.2 nM, 0.76 nM, 13 nM and 1.2 nM for EGFR, HER2,BLKandRIPK2, reapectively. BDTX-189 exhibits anticancer activity.


Targets

EGFR (Cell-free assay); HER2 (Cell-free assay); RIPK2 (Cell-free assay); BLK (Cell-free assay) 0.2 nM(Kd); 0.76 nM(Kd); 1.2 nM(Kd); 13 nM(Kd)


In vitro

BDTX-189 is a potent, selective, irreversible active site inhibitor of the ERBB allosteric mutant oncogene family. BDTX-189 achieves a superior selectivity profile in cell-based assays.


In vivo

BDTX-189 is differentiated by potent, sustained inactivation of multiple allosteric ERBB mutants in vivo. BDTX-189 achieves dose-dependent regression of allosteric HER2 and EGFR tumors at well-tolerated doses.


Cell Research(from reference)

Cell lines:A431 cells, H292 cells 

Incubation Time:0-24 h 

Especificaciones

Sinónimos
2-Propenamide, N-[4-[[3-chloro-4-(2-pyridinylmethoxy)phenyl]amino]-7-[2-(4-morpholinyl)ethoxy]-6-quinazolinyl]- | Tuxobertinib [USAN] | N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-(2-morpholinoethoxy)quinazolin-6-yl)acrylamide | Tuxobertinib [USAN:INN] | tuxobertinib | N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-morphol Show more
Especificaciones y pureza
Moligand™, ≥98%
Mecanismos bioquímicos y fisiológicos
BDTX-189 is a potent and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations with Kd of 0.2 nM, 0.76 nM, 13 nM and 1.2 nM for EGFR, HER2, BLK and RIPK2, reapectively. BDTX-189 exhibits anticancer activity.
Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Grado
Moligand™
Tipo de acción
INHIBITOR, NEGATIVE ALLOSTERIC MODULATOR
Mecanismo de acción
Epidermal growth factor receptor erbB1 negative allosteric modulator
Pureza
≥98%
Propiedades del producto
ALogP
4.401
hba_count
7
Recuento HBD
2
Enlace rotable
11
Nombres e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504773674
SMILES
C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)OCCN5CCOCC5
IUPAC Name
N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-morpholin-4-ylethoxy)quinazolin-6-yl]prop-2-enamide
InChIKey
HIBPKFXWOPYJPZ-UHFFFAOYSA-N
InChI
1S/C29H29ClN6O4/c1-2-28(37)35-25-16-22-24(17-27(25)39-14-11-36-9-12-38-13-10-36)32-19-33-29(22)34-20-6-7-26(23(30)15-20)40-18-21-5-3-4-8-31-21/h2-8,15-17,19H,1,9-14,18H2,(H,35,37)(H,32,33,34)
Isómeros SMILES
C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)OCCN5CCOCC5
Peso molecular
561.03
Reaxys
36046686
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=36046686&ln=

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClaseDiazanaphthalenes
SubclassBenzodiazines
Intermediate Tree Nodes Quinazolines
Direct ParentQuinazolinamines
Alternative Parents Phenoxy compounds  Phenol ethers  N-arylamides  Chlorobenzenes  Alkyl aryl ethers  2-halopyridines  Pyrimidines and pyrimidine derivatives  Morpholines  Imidolactams  Heteroaromatic compounds  Trialkylamines  Amino acids and derivatives  Secondary amines  Oxacyclic compounds  Dialkyl ethers  Carboxylic acid amides  Azacyclic compounds  Organopnictogen compounds  Organochlorides  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Quinazolinamine - Phenoxy compound - N-arylamide - Phenol ether - 2-halopyridine - Halobenzene - Chlorobenzene - Alkyl aryl ether - Imidolactam - Benzenoid - Pyrimidine - Pyridine - Oxazinane - Morpholine - Monocyclic benzene moiety - Heteroaromatic compound - Tertiary aliphatic amine - Tertiary amine - Carboxamide group - Amino acid or derivatives - Oxacycle - Azacycle - Secondary amine - Ether - Dialkyl ether - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Organochloride - Organohalogen compound - Amine - Aromatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups.
External Descriptors Not available
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
ERBB2 Tclin Receptor tyrosine-protein kinase erbB-2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EGFR Tclin Epidermal growth factor receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeFechaArticulo
A2305125A2305125Certificate of AnalysisJul 03, 2026 B414485
L2213053L2213053Certificate of AnalysisJun 09, 2026 B414485
L2213066L2213066Certificate of AnalysisJun 09, 2026 B414485
L2213077L2213077Certificate of AnalysisJun 09, 2026 B414485
L2213080L2213080Certificate of AnalysisJun 09, 2026 B414485
Propiedades químicas y físicas
SolubilidadSolubility (25°C) In vitro DMSO: 25 mg/mL (44.56 mM); Water: Insoluble; Ethanol: Insoluble;
DMSO (mg/ml) Solubilidad máxima100
DMSO (mM) Solubilidad máxima178.243587686933
Agua (mg/ml) Solubilidad máxima<1
Peso molecular561
XLogP33.900
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count11
Exact Mass560.194 Da
Monoisotopic Mass560.194 Da
Topological Polar Surface Area111.000 Ų
Heavy Atom Count40
Formal Charge0
Complexity804.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Seguridad y peligros (GHS)
Reaxys
36046686
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=36046686&ln=
Calculadoras de soluciones
Reseñas

Reseñas de cliente

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.